Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

November 30, 2013

Conditions
Type 2 Diabetes MellitusHypogonadism
Interventions
DRUG

Testosterone

50 mg/dose/day for 24 weeks

DRUG

Placebo

placebo on the skin for 24 weeks

Trial Locations (1)

5000

Department of Endocrinology, Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

lead

Marianne Andersen

OTHER

NCT01560546 - Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter | Biotech Hunter